{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-002873","form_type":"8-K","ticker":"BOLT","cik":"0001641281","company_name":"Bolt Biotherapeutics, Inc.","filed_at":"2022-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.515989+00:00","generated_at":"2026-06-27T01:36:41.564668+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bolt Biotherapeutics CSO David Dornan resigns, stays as consultant for 6 months","bullets":["David Dornan, Ph.D. resigned as Chief Scientific Officer effective March 11, 2022.","Entered consulting agreement for 6 months at $500/hour to assist transition.","Outstanding equity awards will continue to vest during consulting period.","Consultant reports to CEO Randall Schatzman."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-002873","json":"https://secwatch.observer/filing/0000950170-22-002873.json","markdown":"https://secwatch.observer/filing/0000950170-22-002873.md","text":"https://secwatch.observer/filing/0000950170-22-002873.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641281/000095017022002873/0000950170-22-002873-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641281/000095017022002873/bolt-20220301.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T01:36:41.564668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1b4cbb8320","claim":"David Dornan resigned as Chief Scientific Officer at Bolt Biotherapeutics, Inc..","evidence_excerpt":"On March 1, 2022, David Dornan, Ph.D. notified Bolt Biotherapeutics, Inc. of his resignation as our Chief Scientific Officer, effective March 11, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641281/000095017022002873/0000950170-22-002873-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Scientific Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}